Abstract
3,5-Diamino-4-(3-trifluoromethylphenyldiazenyl)-1H-pyrazole was used as a starting scaffold for the synthesis of new pyrazole-based heterocycles to study their effects on the proliferation of three human cancer cell lines; human liver carcinoma cell line (HepG-2), colon cancer cell line (HCT-116) and human breast cancer cell line (MCF-7) using MTT assay. The synthesized compounds were characterized on the basis of IR, 1H NMR, 13C NMR, mass spectral data and elemental analysis results. Cytotoxicity assay results revealed that some of the compounds showed potent growth inhibition against all the cell lines tested, with IC50 values in the range of 0.64–7.73 μg/mL. Breast cancer cells were used for further detailed studies to understand the mechanism of cell growth inhibition and apoptosis-inducing effect of the most active compounds. The results indicated that compounds 3a, 10b and 11a arrested MCF-7 cells at G2/M phase of the cell cycle and might induce apoptosis via caspase-3-dependent pathway. Molecular modeling and binding mode analysis of the most active compounds to caspase 3 active site further provide a synergistic mechanism for their pro-apoptotic effects. In order to explore the structural requirements controlling the observed cytotoxic properties, 3D pharmacophore model was generated.
Similar content being viewed by others
References
Nepali K, Sharma S, Sharm M, Bedi PMS, Dhar KL (2014) Eur J Med Chem 77:422–487. https://doi.org/10.1016/j.ejmech.2014.03.018
Caleta I, Kralj M, Marjanovic M, Bertosa B, Tomic S (2009) J Med Chem 52:1744–1756. https://doi.org/10.1021/jm801566q
Cotter TG (2009) Nat Rev Can 9(7):501–507. https://doi.org/10.1038/nrc2663
Watson AJM (2004) Gut 53(11):1701–1709. https://doi.org/10.1136/gut.2004.052704
Hassan M, Watari H, AbuAlmaaty A, Ohba Y, Sakuragi N (2014) BioMed Res Int 1:1–23. https://doi.org/10.1155/2014/150845
Vera-DiVaio MAF, Freitas ACC, Castro HCA, Albuquerque S, Cabral LM, Rodrigues CR, Albuquerque MG, Martins RCA, Henriques MG, DiasL RS (2009) Bioorg Med Chem 17:295. https://doi.org/10.1016/j.bmc.2008.10.085
Karabacak M, Altıntop MD, Çiftçi HI, Koga I, Otsuka M, Fujita M, Özdemir A (2015) Molecules 20:19066–19084. https://doi.org/10.3390/molecules201019066
Prakash O, Kumar R, Parkash V (2008) Eur J Med Chem 43:435–440. https://doi.org/10.1016/j.ejmech.2007.04.004
Pérez-Fernández R, Goya P, Elguero J (2014) ARKIVOC 2:233–293
Mohamed FM, Mohamed MS, Fathi MM, Shouman SA, Abdelhamid IA (2014) Anti-Can Agents Med Chem 14:1282–1292. https://doi.org/10.1039/C6RA04974E
Toton E, Ignatowicz MK, Bernard J, Kujawski M, Rybczynska J (2013) Physiol Pharmacol 64:115–123 PMID:23568979
Zheng LW, Li Y, Ge D, Zhao BX, Liu YR, Lv HS, Ding J, Miao JY (2010) Bioorg Med Chem Lett 20:4766–4770. https://doi.org/10.1016/j.bmcl.2010.06.121
Farag AM, Ali KAK, El-Debss TMA, Mayhoub AS, Amr AE, Abdel- Hafez NA, Abdulla MM (2010) Eur J Med Chem 45:5887–5898. https://doi.org/10.1016/j.ejmech.2010.09.054
Kumar H, Saini D, Jain SN (2013) Eur J Med Chem 70:248–258. https://doi.org/10.1016/j.ejmech.2013.10.004
Nevagi Reshma J (2014) Der Pharmacia Lett 6(5):285–295
Al-Adiwish WM, Tahir MIM, Siti-Noor-Adnalizawati A, Hashim SF, Ibrahim N, Yaacob WA (2013) Eur J Med Chem 64:464–476. https://doi.org/10.1016/j.ejmech.2013.04.029
Hwang JY, Windisch MP, Jo S, Kim K, Kong S, Kim HC, Kim S, Kim H, Lee ME, Kim Y (2012) Bioorg MedChem Lett 22:7297–7301. https://doi.org/10.1016/j.bmcl.2012.10.123
Ahmed OM, Mohamed MA, Ahmed RR, Ahmed SA (2009) Eur J Med Chem 44:3519–3523. https://doi.org/10.1016/j.ejmech.2009.03.042
Hafez TS, Osman SA, Yosef HAA, Abd El-All AS, Hassan AS, El-Sawy AA, Abdallah MM, Youns M (2013) Sci Pharm 81:339–357. https://doi.org/10.3797/scipharm.1211-07
Hassan AS, Hafez TS, Osman SA (2015) Sci Pharm 83:27–39. https://doi.org/10.3797/scipharm.1409-14
Hassan AS, Hafez TS, Osman SAM, Ali MM (2015) Turk J Chem 39:1102–1113. https://doi.org/10.3906/kim-1504-12
Fadeyi OO, Okoro CO (2008) Tetrahedron Lett 49:4725–4727. https://doi.org/10.1016/j.tetlet.2008.05.120
Aggarwal R, Kumar R, Kumar S, Garg G, Mahajan R, Sharma J (2011) J Fluorine Chem 132:965–972. https://doi.org/10.1016/j.jfluchem.2011.07.029
Singh RP, Shreeve JM (2000) Tetrahedron 56:7613–7632
Hu H, Ge C, Ding L, Zhang A (2010) Molecules 15:7472–7481. https://doi.org/10.3390/molecules15107472
Ranatunge RR, Earl RA, Garvey DS, Janero DR, Gordon Letts L, Martino AM, Murty MG, Richardson SK, Schwalb DJ, Young DV, Zemtseva IS (2004) Bioorg Med Chem Lett 14:6049–6052. https://doi.org/10.1016/j.bmcl.2004.09.073
Sridhar R, Perumal PT, Etti S, Shanmugam G, Ponnuswamy MN, Prabavathyc VR, Mathivanan N (2004) Bioorg Med Chem Lett 14:6035–6040. https://doi.org/10.1016/j.bmcl.2004.09.066
Usachev BI, Obydennov DL, Schenthaler GV, Sosnovskikh VY (2012) Fluorine Chem 137:22–26. https://doi.org/10.1016/j.jfluchem.2012.01.006
Aggarwal R, Bansal A, Mittal A (2013) J Fluorine Chem 145:95–101. https://doi.org/10.1016/j.jfluchem.2012.10.005
Nagahara K, Kawano H, Sasaoka S, Ukawa C, Hirama T, Takada A, Cottam HB, Robins RK (1994) J Het Chem 31:239–243. https://doi.org/10.1002/jhet.5570310140
Elkholy A, Al-Qalaf F, Elnagdi MH (2008) ARKIVOC 14:124–131. https://doi.org/10.3998/ark.5550190.0009.e14
Liu Y, Peterson DA, Kimura H, Schubert D (1997) J Neurochem 69:581–593 PMID:9231715
Huang KB, Chen ZF, Liu YC, Li ZQ, Wei JH, Wang M, Zhang GH, Liang H (2013) Eur J Med Chem 63:76–84. https://doi.org/10.1016/j.ejmech.2013.01.055
Sheen JH, Woo JK, Dickson RB (2003) Br J Can 89:1479–1485. https://doi.org/10.1038/sj.bjc.6601307
Alnemri ES, Livingston DJ, Nichoson DW, Salvesen G, Thornberry NAW, Wong W, Yuan T (1996) Cell 87:171 PMID:8861900
Kim WH, Yeo M, Kim MS, Chun SB, Shin EC, Park JH (2000) Int J Colorectal Dis 15:105–111. https://doi.org/10.1007/s003840050242
Creagh EM, Martin SJ (2001) Biochem Soc Trans 29:696–702. https://doi.org/10.1042/bst0290696
‘Amelio MD (2010) Cell Death Differ 17:1104–1114. https://doi.org/10.1038/cdd.2009.180
Jänicke RU, Sprengart ML, Wati MR, Porter AG (1998) J Biol Chem 273:9357–9360. https://doi.org/10.1074/jbc.273.16.9357
Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kägi D, Hakem A, McCurrach M, Khoo W, Kaufman SA, Senaldi G, Howard T, Mak TW (1998) Genes Dev 12:806–819 PMID: 9512515. PMCID:PMC316633
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fayed, E.A., Eissa, S.I., Bayoumi, A.H. et al. Design, synthesis, cytotoxicity and molecular modeling studies of some novel fluorinated pyrazole-based heterocycles as anticancer and apoptosis-inducing agents. Mol Divers 23, 165–181 (2019). https://doi.org/10.1007/s11030-018-9865-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11030-018-9865-9